SEC Form 4 · accession 0001209191-18-053537

Entasis Therapeutics Holdings Inc. · ETTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

10% Owner

10% Owner

10% Owner

Period of report

Sep 28, 2018

Accepted (ET)

Oct 2, 2018 · 9:39 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001724344

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Sep 28, 2018	C	359,267	—	A	359,267	I	See Footnote
Common Stock^F1,F3,F2	Sep 28, 2018	C	458,425	—	A	842,454	I	See Footnote
Common Stock^F2	Sep 28, 2018	P	337,724	$15.00	A	1,180,178	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series B-1 Tranche A Convertible Preferred Stock^F2,F1	—	Sep 28, 2018	C	7,446,904	D	—	—	Common Stock	359,267	0	I
Series B-1 Tranche B Convertible Preferred Stock^F2,F1	—	Sep 28, 2018	C	9,502,249	D	—	—	Common Stock	458,425	0	I

F1Each share of Series B-1 Tranche A Convertible Preferred Stock and Series B-1 Tranche B Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted into Common Stock on a 20.728-for-one basis upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
F2The reportable securities are owned directly by Pivotal bioVenture Partners Fund I, L.P. ("Pivotal"). Pivotal bioVenture Partners Fund I G.P., L.P. ("Pivotal GP") is the general partner of Pivotal. Pivotal bioVenture Partners Fund I U.G.P., Ltd ("Ultimate General Partner") is the general partner of Pivotal GP. Richard Coles, Peter Bisgaard and Vincent Sai Sing Cheung are directors of the Ultimate General Partner and may, along with the Ultimate General Partner, be deemed to have shared voting and dispositive power over the shares owned by Pivotal.
F3This number includes an aggregate of 24,762 shares of Common Stock received upon the conversion of the Issuer's Preferred Stock as payment of the accrued dividends through September 27, 2018. No dividends will accrue after September 27, 2018.